Literature DB >> 9217011

Characterization of the heparin-binding domain of human extracellular superoxide dismutase.

L A Tibell1, I Sethson, A V Buevich.   

Abstract

The C-terminal, heparin-binding domain of human extracellular superoxide dismutase (hEC-SOD) has been studied as a fusion to human carbonic anhydrase II (HCAII). This technique allows the properties of the EC-SOD domain to be characterized. At the same time, it allows us to differentiate the contributions from the domain, from those properties originating from other parts of EC-SOD. The fusion of the 27 C-terminal amino acids of hEC-SOD to the C-terminal of HCAII (FusCC) resulted in the formation of a monomeric protein, which binds to heparin-Sepharose with approximately the same affinity as the tetrameric hEC-SOD. The structure of the fused C-terminal was characterized by CD and NMR spectroscopy and the data were compatible with the presence of alpha-helical structures as suggested by secondary structure predictions. The NMR data show that the C-terminal of FusCC moves independently from the rest of the protein and that its central part is involved in conformational exchange. The NOESY spectra demonstrate that the C-terminal in both FusCC and hEC-SOD binds to heparin, and that arginine side chains take part in the binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217011     DOI: 10.1016/s0167-4838(97)00024-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  A novel human derived cell-penetrating peptide in drug delivery.

Authors:  Jian Zhao; Peng Gao; Wei Xiao; Li-Qiang Fan; Fu-Jun Wang; Su-Xia Li; Jian-Wen Liu
Journal:  Mol Biol Rep       Date:  2010-11-16       Impact factor: 2.316

Review 2.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

3.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

4.  Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.

Authors:  Fei Gao; Jeffrey R Koenitzer; Jacob M Tobolewski; Dianhua Jiang; Jiurong Liang; Paul W Noble; Tim D Oury
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

Review 5.  Regulation of superoxide dismutase genes: implications in disease.

Authors:  Lu Miao; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2009-05-25       Impact factor: 7.376

6.  The high concentration of Arg213-->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities.

Authors:  Steen V Petersen; Dorte Aa Olsen; John M Kenney; Tim D Oury; Zuzana Valnickova; Ida B Thøgersen; James D Crapo; Jan J Enghild
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

7.  Antimicrobial activity of a C-terminal peptide from human extracellular superoxide dismutase.

Authors:  Mukesh Pasupuleti; Mina Davoudi; Martin Malmsten; Artur Schmidtchen
Journal:  BMC Res Notes       Date:  2009-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.